Stem cell-derived 'spinal cord-like' microtissues afford personalized drug screening
Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, which are required for ...
22 hours ago
0
0